Advertisement

Topics

Sarepta Therapeutics prices $300 million public offering

12:12 EDT 23 Sep 2016 | thePharmaLetter

RNA-targeted therapeutics innovator Sarepta Therapeutics has priced an underwritten public offering of…

Original Article: Sarepta Therapeutics prices $300 million public offering

NEXT ARTICLE

More From BioPortfolio on "Sarepta Therapeutics prices $300 million public offering"

Quick Search
Advertisement